Skip to main content
. 2023 May 29;12(11):3747. doi: 10.3390/jcm12113747
Therapy Medication
CHEMOTHERAPY DOCETAXEL
PEMETREXED (ALIMTA)
PACLITAXEL
NAVELBIN
CYCLOPHOSPHAMIDE
CARBOPLATIN
ETOPOSID
MELPHALAN (ALKERAN)
GEMCITABINE (GEMZAR)
DOXORUBICIN
COMBINATION CHEMOTHERAPY EC (EPIRUBICIN, CYCLOPHOSPHAMIDE)
PACLITAXEL + NAVELBINE
DOXORUBICIN + CYCLOPHOSPHAMIDE
ENDOCRINE THERAPY GOSERELIN (ZOLADEX)
ABIRATERON
LETROZOLE
RIBOCICLIB
FULVESTRANT
LEUPROLIDE ACETATE (ELIGARD)
TAMOXIFEN
BICALUTAMIDE
MOLECULAR-TARGETED THERAPY PALBOCICLIB
BORTEZOMIB
ABEMACICLIB
PERTUZUMAB
TRASTUZUMAB(HERCEPTIN)
OSIMERTINIB
SUNITINIB (SUTENT)
CABOZANTINIB
COMBINATION CHEMOTHERAPY/HORMONOTHERAPY AND TARGETED MOLECULAR THERAPY ATEZOLIZUMAB + ETOPOSID + CRB
CYBORD (CYCLOPHOSPHAMIDE + BORTEZOMIB + DEXAMETHASONE)
TAMOXIFEN + ABEMACICLIB + FULVESTRANT
PALBOCICLIB + FULVESTRANT
PALBOCICLIB + LETROZOLE
AHT ATEZOLIZUMAB
PEMBROLIZUMAB